CRSP logo

CRISPR Therapeutics AG (CRSP) Enterprise Value

Enterprise Value:

$3.38B-$176.31M(-4.95%)
November 18, 2025

Summary

  • As of today, CRSP enterprise value is $3.38 billion, with a fall of -$176.31 million (-4.95%) during the most recent trading session on November 18, 2025.
  • Over the past year, CRSP enterprise value has increased by +$1.08 billion (+47.03%).
  • CRSP enterprise value is now -75.66% below its all-time high of $13.90 billion.

Performance

CRSP Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherCRSPvaluation metrics

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

CRSP Enterprise Value Trends

PeriodPeriodEnterprise ValueEnterprise ValueMarket CapMarket CapPricePrice
1D1 Day-5.0%-3.3%-3.3%
1M1 Month-29.2%-21.5%-22.7%
3M3 Months-1.0%+3.5%-1.3%
6M6 Months+98.9%+52.5%+38.2%
YTDYTD+99.6%+51.0%+35.9%
1Y1 Year+47.0%+27.1%+13.8%
5Y5 Years-47.1%-34.0%-51.0%

CRSP Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month$5.23B-35.3%$3.16B+7.1%
3M3-Month$5.49B-38.4%$3.16B+7.1%
6M6-Month$5.49B-38.4%$1.49B+126.3%
1Y1-Year$5.49B-38.4%$1.06B+218.8%
3Y3-Year$6.05B-44.1%$1.06B+218.8%
5Y5-Year$13.90B-75.7%$1.06B+218.8%
All-TimeAll-Time$13.90B-75.7%$256M+1222.0%

CRSP Enterprise Value History

DateValue
2025
$3.38B(+99.6%)
2024
$1.69B(-52.3%)
2023
$3.56B(+119.5%)
2022
$1.62B(-56.0%)
2021
$3.68B(-62.0%)
DateValue
2020
$9.69B(+244.7%)
2019
$2.81B(+174.3%)
2018
$1.02B(+43.7%)
2017
$713.35M(+45.8%)
2016
$489.20M

FAQ

  • What is CRISPR Therapeutics AG enterprise value?
  • What is the all-time high enterprise value for CRISPR Therapeutics AG?
  • What is CRSP enterprise value year-to-date change?
  • What is CRISPR Therapeutics AG enterprise value year-on-year change?

What is CRISPR Therapeutics AG enterprise value?

The current enterprise value of CRSP is $3.38B

What is the all-time high enterprise value for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high enterprise value is $13.90B

What is CRSP enterprise value year-to-date change?

CRISPR Therapeutics AG enterprise value has changed by +$1.69B (+99.63%) since the beginning of the year

What is CRISPR Therapeutics AG enterprise value year-on-year change?

Over the past year, CRSP enterprise value has changed by +$1.08B (+47.03%)
On this page